Asset Management One Co., Ltd. Exelixis, Inc. Transaction History

Asset Management One Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$20.34 - $23.73 $171,689 - $200,304	-8,441 Reduced 48.63%	8,915 $200,000
Q1 2024 May 02, 2024	BUY	$20.17 - $23.93 $350,070 - $415,329	17,356 New	17,356 $411,000
Q1 2023 Apr 25, 2023	BUY	$16.3 - $19.41 $4,058 - $4,833	249 New	249 $4,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $207,686 - $251,215	-11,190 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $247,858 - $356,849	11,190 New	11,190 $248,000

509

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.